Friday, April 24, 2015

Daniel Hoffman

Possibilities and obstacles in controlling health care costs

Friday, January 30, 2015, 10:33 AM
Good news and bad news on health care typically pile on top of one another in the same way that snowfalls have come to the northeast in rapid succession this winter. So it was that last week there appeared in the news at least a direction for controlling provider costs in health care, even as President... Read more

Remedies for lowering drug prices: From mild to aggressive

Wednesday, January 21, 2015, 5:30 AM
At last the mass media have turned their attention to the reality of excessively high drug prices in the U.S. It wasn't that reporters and editors, during the past several decades, failed to notice how drug prices here are double and triple those of other advanced countries. In fact, for twenty years... Read more

The malevolence of all health care sectors

Wednesday, January 14, 2015, 2:41 PM
The fundamental attribute of nearly all the major health care sectors is the relentless pursuit of profit without consideration of the larger social consequences. Some may call that "amoral greed," but the reader can apply his/her own terms. Add to this reality the fact that some health care competitors... Read more

The two horsemen of pharma's apocalypse

Tuesday, January 6, 2015, 11:57 AM
During the past decade, the pharmaceutical industry abandoned most of the distinctive virtues that originally inspired many people in the Delaware Valley to spend their careers working for it. The main reason for this devolution has been pharma's slavish abandonment of its integrity while catering... Read more

SEPTA's suit against Gilead raises bigger questions

Wednesday, December 17, 2014, 5:30 AM
Last week the regional transportation authority in this area, SEPTA, filed suit against pharmaceutical company Gilead for its “exorbitant pricing” of Sovaldi, a product to treat hepatitis C. SEPTA is a self-funded organization that covers the health benefits for its employees and their... Read more

Vitriolic or naive: Pharma as film noir

Monday, December 8, 2014, 12:17 PM
What a difference a day makes. Last week's posting presented some speculation as to why the board at Sanofi might have fired CEO Chris Viehbacher. The core argument was that the board may have dismissed Viehbacher for committing the unpardonable sin of trying to break pharma’s cartel by agreeing... Read more

Explanations for firing Chris Viehbacher look flimsy

Tuesday, December 2, 2014, 9:16 AM
As unexpected activities at work preempted regular postings during the past several weeks, this piece will provide a catch-up on a prominent story that animated the pharmaceutical industry in October and November. The board of French-based Sanofi, the world's fifth largest pharma (based on sales)... Read more

Where health care is headed

Tuesday, September 30, 2014, 2:23 PM
The trend lines in U.S. health care keep getting clearer. Employers are shifting larger percentages of the coverage costs to their employees (see here). At the same time, private insurers try to evade the Affordable Care Act's prohibition against excluding people with serious or pre-existing conditions... Read more

Two myths of patient recruitment

Tuesday, September 23, 2014, 1:09 PM
An invitation recently arrived by email to attend a podcast purporting to show how promoting clinical studies in social media can seriously boost patient recruitment. The podcasts's underlying premise constitutes yet another contribution to the radically exaggerated, even misleading notion that IT... Read more

Is Novartis' LCZ696 "revolutionary" or just a marginal improvement?

Wednesday, September 10, 2014, 1:02 PM
Over the Labor Day weekend, Novartis presented the results of a trial for its cardiovascular compound, LSC696, at the European Society of Cardiology (ESC) meeting in Barcelona, Spain. Reactions to those results were the number one topic on the pharma blogosphere for several days afterward. Prior... Read more
About this blog

Check Up covers regional health news and a wide array of healthcare topics from pharmaceutical happenings to patient safety. Read about some of our bloggers here.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Hooman Noorchashm, M.D., Ph.D. Cardiothoracic surgeon in the Philadelphia area
Amy J. Reed, M.D., Ph.D. Anesthesiologist and Surgical Intensivist in the Philadelphia Area
Latest Health Videos
Also on Philly.com:
Stay Connected